ENDOCARE_UK_LIMITED - Accounts


Company Registration No. 06768969 (England and Wales)
ENDOCARE UK LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2019
PAGES FOR FILING WITH REGISTRAR
ENDOCARE UK LIMITED
CONTENTS
Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 7
ENDOCARE UK LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2019
31 December 2019
- 1 -
2019
2018
Notes
£
£
£
£
Non-current assets
Property, plant and equipment
4
58,062
75,560
Current assets
Inventories
31,500
30,000
Trade and other receivables
5
46,969
76,878
Cash and cash equivalents
4
17
78,473
106,895
Current liabilities
6
(212,841)
(265,276)
Net current liabilities
(134,368)
(158,381)
Total assets less current liabilities
(76,306)
(82,821)
Non-current liabilities
7
(26,426)
(41,147)
Net liabilities
(102,732)
(123,968)
Equity
Called up share capital
8
100
100
Retained earnings
(102,832)
(124,068)
Total equity
(102,732)
(123,968)

The director of the company has elected not to include a copy of the income statement within the financial statements.true

For the financial year ended 31 December 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

ENDOCARE UK LIMITED
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT
31 DECEMBER 2019
31 December 2019
- 2 -
The financial statements were approved and signed by the director and authorised for issue on 4 April 2020
Mr M Sultan
Director
Company Registration No. 06768969
ENDOCARE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2019
- 3 -
1
Accounting policies
Company information

Endocare UK Limited is a private company limited by shares incorporated in England and Wales. The registered office is Devonshire House, 1 Devonshire Street, London, W1W 5DR. The company's place of business is 99 Harley Street, London, W1G 8AQ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

The financial statements are prepared on the going concern basis on the assumption that continued financial support is given by the company's director.true

1.3
Revenue
Turnover represents fees receivable for the provision of endodontic dental treatment. Fees are recognised when the right to consideration arises.
1.4
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 5 years.

1.5
Property, plant and equipment

Property, plant and equipment are initially measured at cost and subsequently measured at cost net of depreciation and any impairment losses.

Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:
Improvements to leasehold
Over period of lease
Plant and machinery etc.
10% on cost
Fixtures, fittings & equipment
15% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Inventories

Inventories are stated at the lower of cost and estimated selling price less costs to complete and sell and comprise direct materials used in the provision of endodontic dental treatment. At each reporting end date, an assessment is made for impairment.

ENDOCARE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
1
Accounting policies
(Continued)
- 4 -
1.7
Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including trade and other payables and bank loans, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

ENDOCARE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
1
Accounting policies
(Continued)
- 5 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense. The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received. Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the statement of financial position as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 11 (2018 - 11).

ENDOCARE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
- 6 -
3
Intangible fixed assets
Goodwill
£
Cost
At 1 January 2019 and 31 December 2019
425,000
Amortisation and impairment
At 1 January 2019 and 31 December 2019
425,000
Carrying amount
At 31 December 2019
-
At 31 December 2018
-
4
Property, plant and equipment
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 January 2019
255,192
360,111
615,303
Additions
-
9,543
9,543
At 31 December 2019
255,192
369,654
624,846
Depreciation and impairment
At 1 January 2019
241,451
298,292
539,743
Depreciation charged in the year
13,087
13,954
27,041
At 31 December 2019
254,538
312,246
566,784
Carrying amount
At 31 December 2019
654
57,408
58,062
At 31 December 2018
13,741
61,819
75,560
5
Trade and other receivables
2019
2018
Amounts falling due within one year:
£
£
Trade receivables
9,054
10,170
Other receivables
37,915
66,708
46,969
76,878

Included in debtors is a rent deposit of £6,613 (2018: £6,613) which is secured by way of a charge over that deposit and is due for repayment after more than one year.

ENDOCARE UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
- 7 -
6
Current liabilities
2019
2018
£
£
Bank loans and overdrafts
107,832
135,974
Trade payables
5,698
27,555
Corporation tax
33,326
39,640
Other taxation and social security
12,380
11,566
Other payables
53,605
50,541
212,841
265,276
7
Non-current liabilities
2019
2018
£
£
Other payables
26,426
41,147
8
Called up share capital
2019
2018
£
£
Ordinary share capital
Issued and fully paid
100 Ordinary shares of £1 each
100
100
9
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2019
2018
£
£
Between one and five years
434,827
201,051
10
Directors' transactions

At the year end the director owed the company £4,777 (2018: £15,755). This amount will be repaid within 9 months of the year end.

 

2019-12-312019-01-01false06 April 2020CCH SoftwareCCH Accounts Production 2020.200No description of principal activityMr M SultanMr M Sultan067689692019-01-012019-12-31067689692019-12-31067689692018-12-3106768969core:LandBuildings2019-12-3106768969core:OtherPropertyPlantEquipment2019-12-3106768969core:LandBuildings2018-12-3106768969core:OtherPropertyPlantEquipment2018-12-3106768969core:CurrentFinancialInstrumentscore:WithinOneYear2019-12-3106768969core:CurrentFinancialInstrumentscore:WithinOneYear2018-12-3106768969core:CurrentFinancialInstruments2019-12-3106768969core:CurrentFinancialInstruments2018-12-3106768969core:Non-currentFinancialInstruments2019-12-3106768969core:Non-currentFinancialInstruments2018-12-3106768969core:ShareCapital2019-12-3106768969core:ShareCapital2018-12-3106768969core:RetainedEarningsAccumulatedLosses2019-12-3106768969core:RetainedEarningsAccumulatedLosses2018-12-3106768969bus:CompanySecretaryDirector12019-01-012019-12-3106768969core:Goodwill2019-01-012019-12-3106768969core:LandBuildingscore:OwnedOrFreeholdAssets2019-01-012019-12-3106768969core:PlantMachinery2019-01-012019-12-3106768969core:FurnitureFittings2019-01-012019-12-3106768969core:NetGoodwill2018-12-3106768969core:LandBuildings2018-12-3106768969core:OtherPropertyPlantEquipment2018-12-31067689692018-12-3106768969core:OtherPropertyPlantEquipment2019-01-012019-12-3106768969core:LandBuildings2019-01-012019-12-3106768969core:WithinOneYear2019-12-3106768969core:WithinOneYear2018-12-3106768969bus:OrdinaryShareClass12019-01-012019-12-3106768969bus:OrdinaryShareClass12019-12-3106768969bus:PrivateLimitedCompanyLtd2019-01-012019-12-3106768969bus:SmallCompaniesRegimeForAccounts2019-01-012019-12-3106768969bus:FRS1022019-01-012019-12-3106768969bus:AuditExemptWithAccountantsReport2019-01-012019-12-3106768969bus:Director12019-01-012019-12-3106768969bus:CompanySecretary12019-01-012019-12-3106768969bus:FullAccounts2019-01-012019-12-31xbrli:purexbrli:sharesiso4217:GBP